Physician profile
Franz Velarde
NPI 1093795494
$942.30
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2021: $59.65 · 2022: $136 · 2023: $173 · 2024: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galt Medical | $234.94 | 2019 | |
| Boston Scientific Corporation | $233.56 | 2021-2023 | Therasphere Y90 Glass Microspheres 10 Gbq, Truselect |
| Novo Nordisk INC | $124.92 | 2024 | Ozempic |
| Argon Medical Devices, INC. | $106.53 | 2022 | |
| Genentech USA, INC. | $100.90 | 2019 | |
| Abbott Laboratories | $98.65 | 2024 | Freestyle Libre 3 |
| Tactile Systems Technology INC | $42.80 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franz Velarde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.